MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest and other
income, net
$3,211,000
Net loss
-$24,208,000
Total other income,
net
$2,345,000
Interest expense
$866,000
Loss from operations
-$26,553,000
License revenue
$20,000,000
Total operating
expenses
$46,553,000
Research and development
$34,148,000
General and
administrative
$12,405,000
Back
Back
Income Statement
source: myfinsight.com
Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE)